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OBJECTIVES We sought to model an algorithm for noninvasive identification of angiographically obstructive
three-vessel and/or left main disease based on conventional cardiac risk assessment and site and
extent of coronary calcium determined by electron-beam computed tomography (EBCT).
BACKGROUND Such an algorithm would greatly facilitate clinical triage in symptomatic patients with no
previous diagnosis of coronary artery disease (CAD).
METHODS We examined 291 patients with suspected, but not previously diagnosed, CAD who underwent
coronary angiography for clinical indications. Cardiac risk factors were determined as defined by
the National Cholesterol Education Program. An EBCT scan was performed in all patients, and
a coronary calcium score (Agatston method) was computed. Total per-patient calcium scores and
separate scores for the major coronary arteries were generated. These scores were also analyzed for
localization of coronary calcium in the more distal versus proximal tomographic sections. These
parameters and the risk factors were considered for the model described in the following section.
RESULTS Sixty-eight patients (23%) had angiographic three-vessel and/or left main CAD. Multiple
logistic regression analysis determined male sex, presence of diabetes and left anterior descending
(LAD) and circumflex (LCx) coronary calcium scores, independent from more distal calcium
localization, as independent predictors for identification of three-vessel and/or left main CAD.
Based on this four variable model, a simple noninvasive index (NI) was constructed as the
following: loge(LAD score) 1 loge(LCx score) 1 2[if diabetic] 1 3[if male]. Receiver operating
characteristic curve analysis for this NI yielded an area under the curve of 0.88 6 0.03 (p ,
0.0001) for separating patients with, versus without, angiographic three-vessel and/or left main
CAD. Various NI cutpoints demonstrated sensitivities from 87–97% and specificities from
46–74%. The NI values .14 increased the probability of angiographic three-vessel and/or left
main CAD from 23% (pretest) to 65–100% (posttest), and NI values ,10 increased the
probability of no three-vessel and/or left main CAD from 77% (pretest) to 95–100% (posttest).
CONCLUSIONS On the basis of a simple algorithm (“noninvasive index”), EBCT calcium scanning in
conjunction with risk factor analysis can rule in or rule out angiographically severe disease, i.e.,
three-vessel and/or left main CAD, in symptomatic patients. (J Am Coll Cardiol 1999;33:
444–52) © 1999 by the American College of Cardiology
The identification of symptomatic patients with angio-
graphic three-vessel and/or left main coronary artery disease
(CAD) is becoming increasingly important. These patients
are at high risk (1–3) and usually require coronary angiog-
raphy and consideration for revascularization, whereas fur-
ther noninvasive evaluation and risk stratification may be
justified for patients with less severe CAD (4).
Coronary risk factors do not allow individual discrimina-
tion of severity of angiographic CAD (5,6) or adverse
outcomes (7), but are useful prognostic indicators in large
patient populations. However, for triage of patients who
may require coronary catheterization, one also relies on
more direct measures of the extent and severity of CAD as
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can be provided by stress echocardiography (8,9) or radio-
nuclide perfusion imaging (10,11).
As opposed to other noninvasive cardiac imaging modal-
ities focusing on the physiological consequences of coronary
obstruction, coronary calcium quantified by electron-beam
computed tomography (EBCT) represents anatomic disease
itself, i.e., coronary plaque burdens (12,13). Coronary cal-
cium predicts the presence (14,15) and extent (16) of
obstructive angiographic CAD, and the amounts of detect-
able calcified plaque can be used to estimate the likely
severity of maximum angiographic stenosis (17). However,
depending on a patient’s risk profile, consideration of
coronary calcium alone for estimation of coronary disease
can be misleading in some cases (18,19). Combination of
risk factor assessment and EBCT should be superior to
either method alone for the identification of angiographic
three-vessel and/or left main disease, but this has not been
previously explored. We therefore sought to model a clini-
cally applicable noninvasive index based on the analysis of
conventional cardiac risk factors as defined by the National
Cholesterol Education Program (NCEP) (20) and EBCT-
derived quantity of coronary calcium.
METHODS
Patients. The research protocol was approved by the Mayo
Clinic Institutional Review Board. Consecutive patients
who underwent diagnostic coronary angiography for clinical
indications were invited to participate in the research
protocol if they had no previous arteriographic documenta-
tion of CAD, coronary artery bypass surgery or previous
cardiac transplant surgery. Also, no patient had unstable
angina or underwent angioplasty at the time of initial
angiography. After signed informed consent, EBCT scan-
ning was performed on an average of one day following
arteriography. Results from subsets of this patient popula-
tion have been published previously (14,17,21,22). On the
basis of a clinical diagnosis of previous myocardial infarction
or signs of ischemia in the resting electrocardiogram, 31
patients with known CAD before admission were excluded
to obtain a more homogeneous sample. In the remaining
291 patients, the most common indication for coronary
angiography was chest pain (typical or atypical angina) in
205 patients (71%). Thirty nine patients (13%) had abnor-
mal conventional stress tests, 21 (7%) had unexplained
exertional dyspnea, 19 (7%) were examined preoperatively
(usually for valvular heart disease), six (2%) had congestive
heart failure, and 1 was examined for a disability claim.
Coronary angiography. Coronary angiography was per-
formed by the Judkins technique with a minimum of five
views of the left system and two views of the right system.
The angiograms were analyzed according to the coronary
segmental classification proposed by the Coronary Artery
Surgery Study (CASS) investigators (5). The maximum
percent diameter stenosis in any of the 27 coronary seg-
ments was visually assessed by two experienced angiogra-
phers who were unaware of the results of EBCT. Segments
were defined as containing no or nonobstructive stenoses
(0% to ,50% luminal diameter narrowing), or stenoses
from 50% to 100% (obstructive disease). This allowed
classification of patients according to the presence or ab-
sence of obstructive three-vessel and/or left main disease. In
case of a disagreement in the interpretation of a given
angiogram, it was arbitrated with the help of a third
angiographer as described previously (17).
Cardiac risk factors. We used the current NCEP defini-
tions for cardiac risk factors (20), taking into account age
and gender, family hisotry of coronary artery disease, current
cigarette smoking, hypertension (systolic and/or diastolic
blood pressure values $140 mmHg and $90 mmHg,
respectively, antihypertensive treatment, or both), diabetes
mellitus and total and high-density lipoprotein (HDL)-
cholesterol. Analysis of fasting total cholesterol and triglyc-
erides was performed in 260 patients with EBCT. No
patients were taking lipid-lowering medications at the time
of study-entry. HDL-cholesterol was determined in 236
patients with EBCT, in whom the ratio of total/HDL-
cholesterol was computed.
Electron-beam computed tomography. High resolution,
noncontrast enhanced EBCT examinations (Imatron
C-100 scanner, Imatron Inc., South San Francisco, Cali-
fornia) were performed in a manner described previously
(14,17). In all subjects, 40 contiguous, 3 mm thick, trans-
axial images were done commencing at the root of the aorta
and proceeding caudad through the apex of the heart. For
each study, a calcium score was determined using the
methods of Agatston and colleagues (23). This algorithm
has been widely used in research and clinical studies
(12–14,16,17,21,22). The calcium score is the product of
the area of coronary artery calcium (at least two contiguous
pixels with a computed tomography (CT) density $130
Hounsfield Units) and a factor rated 1–4 dictated by the
maximum CT density within that lesion. A calcium score
was calculated for each of the major coronary arteries (left
main, left anterior descending, left circumflex and right
coronary arteries) and the entire epicardial coronary system
(“total calcium score”). In addition, the calcium score per
Abbreviations and Acronyms
CAD 5 coronary artery disease
CASS 5 Coronary Artery Surgery Study
CT 5 computed tomography
EBCT 5 electron-beam computed tomography
HDL 5 high-density lipoprotein
LAD 5 lLeft anterior descending coronary artery
LCx 5 left circumflex coronary artery
LDL 5 low-density lipoprotein
NI 5 noninvasive index
ROC 5 receiver operating characteristic
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tomographic level was computed as a measure of the
distribution of coronary calcium from proximal (base of the
heart) to distal (apex). All EBCT analyses were performed
without knowledge of the angiographic CAD severity.
Statistics. Statistical analyses were performed using the
SPSS (versions 6.1.4 and 8.0, SPSS Inc., Chicago, Illinois)
and SAS (version 6.08, SAS Institute, Cary, Indi-
ana) software packages. Values are reported as mean 6 SD
unless otherwise indicated. Consistent with previous reports
(14–17,22–24), total calcium scores in the present study
comprised a great range of values (0 through 7,633), but
were mostly well below 1,000, with the 75th percentile at
545. To minimize the statistical influence of extreme values,
all calcium score values were transformed to the natural
logarithmic scale (24). Independent predictors of the pres-
ence of angiographic three-vessel and/or left main disease
were determined by multiple logistic regression analysis. On
the basis of this analysis, a “noninvasive index” (NI) of
severe angiographic CAD was generated, according to the
coefficients of the independent predictors. These coefficients
can be interpreted as indicating the relative weight of the
predictors with respect to the dependent variable. The NI
was dichotomized at 10 equally spaced cutpoints for tabu-
lation of sensitivity and specificity and related measures,
whereas for all other calculations, the complete range of the
NI was used. The standard errors for sensitivity and speci-
ficity were determined as described by Diamond and For-
rester (25). Receiver operating characteristic (ROC) curve
analysis was generated to test the predictive discrimination
of patients with or without three-vessel and/or left main
CAD. To analyze the predictive discrimination of the NI
compared with either only risk factor variables or only
EBCT-derived calcium score variables, the areas under
these ROC curves were generated and tested for significant
differences (26). The ROC curves were derived from mul-
tiple logistic regression analyses. These analyses identified
independent risk factor or calcium score predictors based
only on all risk factor or all calcium score variables, respec-
tively. The predicted values from these analyses represented
the aggregate predictive information of the model and were
entered into the ROC curve analysis.
Finally, to analyze the predictive value of a positive or
negative result at each NI cutpoint, probability ratios were
computed on the basis of positive and negative likelihood
ratios (27). The positive likelihood ratio (1)LR was defined
as follows:
~ 1 !LR 5
Sensitivity
1 2 Specificity
[1]
The negative likelihood ratio (2)LR was defined as follows:
~ 2 !LR 5
Specificity
1 2 Sensitivity
[2]
A positive or negative test result was defined as a value of
the NI above or below specific cutpoints. According to
Bayes’ theorem (27), the posttest probability of (severe
angiographic) disease after a positive test result was defined
as follows:
~ 1 !PTPD~%! 5
PPD
PPD 1 PPN/~ 1 !LR
z 100 [3]
(1)PTPN means “posttest probability of disease after a
positive test result,” PPD mean “pretest probability of
disease,” and PPN means “pretest probability of no disease.”
The posttest probability of no (severe angiographic) disease
after a negative test result was defined as follows:
~ 2 !PTPN~%! 5
PPN
PPN 1 PPD/~ 2 !LR
z 100 [4]
(2)PTPN means “posttest probability of no disease after a
negative test result.” The pretest probabilities of disease and
no disease, referring to angiographic three-vessel and/or left
main CAD, were estimated empirically, i.e., on the basis of
the actual angiographic findings in our patients. As is
explained in more detail in the following section, the
prevalence of three-vessel and/or left main CAD in our
patients was very comparable to that found in the CASS
registry with 24,595 patients (2), and thus seemed to offer a
reasonable estimate.
For all statistical evaluations, a 2-tailed p-value ,0.05
was considered significant.
RESULTS
Patient demographics. Of the 291 patients, 68 (23%) had
angiographically significant three-vessel and/or left main
disease. Risk factors are listed in Table 1. Table 2 gives
EBCT total calcium scores and calcium scores separately for
the major coronary arteries. Twenty seven patients (9%) had
no coronary calcium detected by EBCT, 38 (13%) had
calcium in one of the major coronary arteries, 62 (21%) in 2,
111 (38%) in 3, and 53 (18%) in all four. In the left coronary
system (left main, left anterior and left circumflex coronary
arteries), 90% of all calcified lesions were detected in the 14
more proximal (vs. 26 more distal) levels, and 98% in the 20
more proximal (vs. 20 more distal) levels. In the right
coronary artery, 90% of all calcified lesions were detected in
the 30 more proximal (vs. 10 more distal) levels, and 98% in
the 36 more proximal (vs. 4 more distal) levels.
Predicting angiographic three-vessel and/or left main
disease. Multivariate logistic regression analysis identified
male sex, diabetes mellitus, age, and, with borderline sig-
nificance (p 5 0.06), family history as independent risk
factor predictors of angiographic three-vessel and/or left
main disease. Total cholesterol values or, alternatively, the
ratio of total/HDL-cholesterol, and calculated LDL-
cholesterol levels did not remain in the model. This was also
true for smoking and systemic hypertension. Considering
only EBCT-derived variables, coronary calcium scores sep-
arately generated for the left circumflex and left anterior
descending coronary arteries (LAD) were independent pre-
dictors. Figure 1 shows that left circumflex (LCx) coronary
calcium scores enabled the best separation between patients
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with versus without three-vessel and/or left main disease,
followed by total calcium scores and left anterior descending
coronary calcium scores. Although total calcium scores were
independently predictive of severe angiographic disease,
they were removed from the model when separate left
anterior descending and circumflex coronary calcium scores
were added. A variable defined as “the number of major
coronary arteries with coronary calcium identified by
EBCT” was not retained in the model. This was also true
for the number of major coronary arteries with calcium
scores above specific cutpoints chosen to optimize detection
of obstructive angiographic stenoses in each respective
vessel. Finally, presence or amount of coronary calcium in
the more distal tomographic levels (distal to 90% or 98% of
all calcified lesions, respectively) was not independently
predictive. This was true for the level-by-level analysis of
total scores as well as for separate analyses of scores for the
left and right coronary systems. Regression analysis of risk
factor variables and EBCT-derived variables together iden-
tified male sex, diabetes and separate left anterior descend-
ing and left circumflex coronary calcium scores as indepen-
dent predictors of angiographic three-vessel and/or left
main disease (Table 3).
Based on the logistic regression model of risk factor and
EBCT variables and the four independently predictive
variables, a simple noninvasive index (NI) was constructed
by using the coefficients given in Table 3, which were
multiplied by two and then rounded to obtain integers. The
Table 1. Cardiac Risk Factor Characteristics of the Patients With Angiographic Three-Vessel
and/or Left Main Disease and of the Overall Patient Sample
Risk Factor
Variables
Angiographic
Three-Vessel and/or
Left Main Disease
(n 5 68)
No angiographic
Three-Vessel and/or
Left Main Disease
(n 5 223)
All Patients
(n 5 291)
Age (years) 61 6 10* 54 6 11 56 6 11
Male sex (number [%]) 62 [91]* 165 [74] 227 [78]
Present smoking (number [%]) 11 [16] 59 [27] 70 [24]
Diabetes (number [%] 15 [22]* 27 [12] 42 [14]
Family history (number [%]) 41 [60] 107 [48] 148 [51]
Systemic hypertension (number [%]) 37 [54] 94 [42] 131 [45]
Total cholesterol (mg/dL) 221 6 37 219 6 53 219 6 50
HDL-cholesterol (mg/dL) 43 6 13 43 6 15 43 6 15
Total/HDL-cholesterol 5.6 6 1.9 5.5 6 1.9 5.5 6 1.9
Triglycerides (mg/dL) 163 6 94 194 6 149 187 6 139
*p , 0.05 vs. No angiographic three-vessel and/or left main disease. HDL 5 high-density lipoprotein.
Table 2. EBCT Characteristics (Loge-Transformed Scores) of the Patients With Angiographic
Three-vessel and/or Left Main Disease and of the Overall Patient Sample
Calcium Score
Variables
Angiographic
Three-Vessel and/or
Left Main Disease
(n 5 68)
No Angiographic
Three-vessel and/or
Left Main Disease
(n 5 223)
All Patients
(n 5 291)
Total calcium score 6.3 6 1.5* 3.7 6 2.4 4.3 6 2.5
(mean 6 SD [median;
25th, 75th percentile])
[6.6; 5.8, 7.3] [4.1; 1.5, 5.8] [5.0; 2.1, 6.3]
LM score 1.0 6 1.7* 0.5 6 1.2 0.6 6 1.3
(mean 6 SD [median;
25th, 75th percentile])
[0.0; 0.0, 1.9] [0.0; 0.0, 0.0] [0.0; 0.0, 0.0]
LAD score 5.5 6 1.5* 2.9 6 2.4 3.5 6 2.4
(mean 6 SD [median;
25th, 75th percentile])
[5.9; 4.7, 6.5] [2.8; 0.0, 5.0] [4.2; 0.8, 5.6]
LCx score 4.4 6 1.9* 1.7 6 1.9 2.3 6 2.2
(mean 6 SD [median;
25th, 75th percentile])
[4.8; 3.5, 5.6] [0.9; 0.0, 3.3] [1.7; 0.0, 4.4]
RCA score 4.7 6 2.2* 2.1 6 2.1 2.7 6 2.4
(mean 6 SD [median;
25th, 75th percentile])
[5.2; 3.3, 6.3] [1.5; 0.0, 3.8] [2.2; 0.4, 4.9]
*p , 0.05 vs. No angiographic three-vessel and/or left main disease. LAD 5 left anterior descending coronary artery, LM 5
left main stem, LCx 5 left circumflex coronary artery, RCA 5 right coronary artery.
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NI represented the aggregate information for predicting the
probability of angiographic three-vessel and/or left main
coronary artery disease.
Noninvasive Index 5
Loge~LAD! 1 Loge~LCx! 1 2@if diabetic# 1 3@if male#
“Loge(LAD)” and “Loge(LCx)” are separate calcium
scores for the LAD and (LCx), respectively, transformed to
the natural logarithmic scale. The NI ranged from 0
through 20.32 in our patients. Figure 2 shows that using
ROC characteristic analysis, the NI yielded an area under
the curve (AUC) of 0.88 6 0.03 (6SEM) for separation of
patients with versus without angiographic three-vessel
and/or left main disease. This was a significantly better
predictive discrimination than risk factors alone (AUC 5
0.77 6 0.04, p-value for difference 5 0.002) and an
apparent trend compared with EBCT-derived variables
alone (AUC 5 0.86 6 0.03, p-value for difference 5 0.051).
All three curves shown in Figure 2 were significantly
different from a random distribution, i.e., an AUC of 0.5.
Sensitivity and specificity analyses. Using the NI, a cut-
point of 11.20 yielded a sensitivity of 82 6 5% (6SEM, 56
of 68 patients with severe angiographic disease correctly
classified), a specificity of 80 6 3% (162 of 223 patients
without severe angiographic disease correctly classified), a
positive predictive value of 56 6 3%, and a negative
predictive value of 94 6 3%. From a clinical and screening
perspective, a model with a high sensitivity rather than
specificity, and accordingly high negative predictive values,
would be desirable (26). To give an overview of how the NI
might be interpreted clinically, it was categorized into 10
cells so that a score of 0 through ,2 was “1”; 2 through ,4
was “2”; and so forth, with scores $18 being “10” (Table 4).
With higher categories of the NI, more patients had severe
angiographic disease (p , 0.0001, x2 test). Depending on
different cutpoints of the categorized NI, varying sensitivi-
ties and specificities for the prediction of severe angio-
graphic disease were generated, as demonstrated in Table 4.
For example, choosing as cutpoint a categorized NI of 3,
sensitivity was 97 6 2%, and specificity was 46 6 3%. At
this same cutpoint, positive and negative likelihood ratios
were 1.80 and 15.33, respectively, indicating high posttest
odds of no disease relative to the pretest estimate of no
disease and thus an increased rule-out power (27). A
cutpoint of 7, on the other hand, was associated with a
sensitivity of 40 6 6% and a specificity of 96 6 1%. Positive
and negative likelihood ratios were 8.85 and 1.60, respec-
tively, indicating an increased rule-in power at this cutpoint.
Posttest probabilities of disease or no disease after a
positive or negative test result, respectively, are shown in
Table 4 and Figure 3. Posttest probabilities of disease could
not be calculated at the extreme ends of the NI-range,
because sensitivities and specificities regarding the detection
Table 3. Independent Predictors of Angiographic Three-Vessel and/or Left Main Disease
Variable Coefficient Standard Error chi-Square p-Value
Male Sex 1.47 0.58 6.46 0.011
Diabetes Mellitus 1.11 0.50 4.93 0.026
LCx Calcium Score 0.42 0.11 16.28 0.0001
LAD Calcium Score 0.40 0.12 10.49 0.0012
Abbreviations as in Table 2.
Multivariate logistic regression analysis in 291 patients. The coefficient of the intercept was22.74 6 0.81.
Figure 1. Boxplot of the range of loge-transformed total calcium scores and calcium scores per major coronary artery in patients with (“1”)
or without (“0”) angiographic three-vessel and/or left main CAD. The boxes represent 25th through 75th percentiles, and the lines in the
boxes represent the median values. The whiskers show the smallest and largest observed values within 1.5 box-lengths of the 25th and 75th
percentiles, respectively. All calcium scores shown in this figure, i.e., total and major coronary artery scores, discriminated between the
presence versus the absence of three-vessel and/or left main disease (p , 0.0001 for all comparisons, except LM; p 5 0.01). LAD 5 left
anterior descending coronary artery, LCx 5 left circumflex coronary artery, LM 5 left main coronary artery, RCA 5 right coronary artery,
total 5 complete coronary tree.
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of angiographic three-vessel and/or left main CAD were
100%. On the basis of the actual angiographic findings, the
pretest probability of (severe angiographic) disease was 23%
in our patients (solid line in Figure 3a). From Table 4 and
Figure 3, it can be appreciated that relative to the pretest
value, the posttest probability of disease increased with
greater NI cutpoint values. Relative to the pretest probabil-
ity of no disease, i.e., 77%, the posttest probability of no
disease increased with smaller NI cutpoint values. Figure 3a
shows that a relatively high NI in the range above 14
increased the probability of disease to above 65% (arrow).
As shown in Figure 3b, a relatively low NI of less than 10
increased the probability of no disease to above 95% (arrow).
Most patients, 209 of 291 (72%), had NI values .14 or
,10.
DISCUSSION
In the present investigation, only patients with suspected,
but not previously known, CAD and no diagnostic signs of
ischemia on the resting electrocardiogram were examined.
Our results demonstrate that in these patients, noncontrast
EBCT calcium scanning in conjunction with risk factor
analysis can be used to noninvasively identify angiographic
three-vessel and/or left main CAD. We constructed a
simple algorithm, the NI, on the basis of the independent
predictors of angiographic three-vessel and/or left main
CAD in our patients, i.e., male sex, diabetes, and left
anterior descending and circumflex coronary calcium scores
(Table 3). Using cutpoints of this NI ranging from 4
through 10, sensitivities on the order of 87–97% and
specificities on the order of 46–73% were generated (Table
4). On the basis of the actual prevalence of severe disease in Ta
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Figure 2. Receiver operating characteristic (ROC) curve analysis
for separation of the presence or absence of angiographic three-
vessel and/or left main disease. Comparison between noninvasive
index (solid thick line), EBCT-derived parameters alone, i.e.,
separate calcium scores for the left anterior descending and left
circumflex arteries (solid fine line), and risk factors alone (dotted
fine line). The area under the ROC curves (mean 6 SEM) were
0.88 6 0.03 for the NI, 0.86 6 0.03 for the EBCT parameters,
and 0.77 6 0.04 for the risk factors. Each was significantly
different from a random distribution (dashed line).
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our patients, i.e., angiographic three-vessel and/or left main
CAD, high NI values .14 increased the probability of
severe disease from 23% to .65%, and low NI values ,10
increased the probability of no severe disease from 77% to
.95% (Fig. 3). Most patients (72%) had NI values in this
range. No patients with an NI # 4.98 (n 5 86) and 30 of
42 patients (71%) with an NI $ 13.75 had angiographic
three-vessel and/or left main CAD. Therefore, the NI as
developed has potential to be useful in selecting symptom-
atic patients who probably should be sent for angiography
(high NI) versus those who probably should have further
noninvasive stratification (low NI).
Patient demographics. The prevalence in the current in-
vestigation of 23% of patients with angiographic three-
vessel and/or left main CAD was comparable to that of 28%
in 24,595 patients enrolled in the CASS (2) (p 5 0.085).
Total cholesterol levels were somewhat lower than reported
in the early 1980s in CASS patients (5) and other, inde-
pendent symptomatic patient cohorts (28), but were com-
parable to more recent reports (29,30). Also, the prevalence
of the nonlipid risk factors was very similar to that in these
recent reports (29,30) with the exception of less active
smokers among our patients. This cohort thus seems fairly
representative of symptomatic patients currently referred for
coronary angiography.
Combination of EBCT and risk factors. The NI was
clearly a superior discriminator of patients with versus
without severe disease compared with use of the risk factors
measured in our study alone (Fig. 2), but the enhanced
discrimination compared with the use of EBCT-derived
calcium scores alone did not quite reach significance (p 5
0.051). Although it is possible that the association of
calcium score values with angiographic three-vessel and/or
left main CAD is indeed so strong that the role for risk
factor predictors is diminished, one should keep in mind
that the sample size of the current investigation was com-
parably small. Obviously, clinical decisions should not rely
on a single test such as EBCT, and future studies with larger
populations may well demonstrate a greater relative impor-
tance of risk factor variables. Also, the newer hemostatic
and inflammatory risk factors such as fibrinogen and
C-reactive protein (31) were not available. Cardiovascular
risk factor exposure varies considerably across populations,
dictated by cultural, geographic, and ethnic attributes,
among other factors (32). It is therefore conceivable that
risk factors other than those determined by the present
investigation predict angiographic three-vessel and/or left
main CAD in other patient cohorts. An interesting obser-
vation was that, although lipids are important factors in the
development of atherosclerosis, they were of little value for
separating degrees of severity of angiographic CAD in our
regression model. This is consistent with previous reports
released by us (in an independent patient population) (24)
and others (5,28,30) stating that lipid risk factors are better
discriminators of the presence or absence, rather than the
severity of, coronary atherosclerotic disease.
EBCT and coronary angiography. In our opinion, the
EBCT-derived predictors of severe angiographic disease
identified in this investigation can be expected to be similar
across various patient populations. Coronary calcium is
representative of underlying coronary atherosclerotic plaque
and plaque burden (12,13,33) and should thus have rela-
tively continuous associations with atherosclerotic disease
severity. It was not surprising that separate calcium scores
Figure 3. Illustration of the power of the NI to rule in (a) or rule
out (b) angiographic three-vessel and/or left main disease. Posttest
probabilities of disease could not be calculated at the extreme ends
of the noninvasive index, because sensitivities and specificities
regarding the detection of angiographic three-vessel and/or left
main disease were 100%. (a) The noninvasive index is represented
on the X-axis and the posttest probability of severe angiographic
disease after a positive test result on the Y-axis ((1)PTPD). The
solid horizontal line represents the pretest probability of severe
angiographic disease, i.e., 23%. Increasing values of the NI
enhance the probability of severe angiographic disease (posttest) to
levels above 65–70% (arrow). (b) The NI is represented on the
X-axis and the posttest probability of no severe angiographic
disease after a negative test result on the Y-axis ((2)PTPN). The
solid horizontal line represents the pretest probability of no severe
angiographic disease, i.e., 77%. Decreasing values of the NI
enhance the probability of no severe angiographic disease (posttest)
to levels above 95% (arrow).
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generated for the left circumflex and left anterior coronary
arteries remained in the regression model, whereas total
calcium scores did not. Statistically, generation of a total
score out of several per-vessel scores leads to a loss of
information. In addition, coronary atherosclerosis, and cor-
onary calcification, appears first in the proximal portions of
the LAD (13,34). Coronary calcification is observed com-
parably late in the atherosclerotic disease process in the left
circumflex coronary artery (13,34,35). Thus, defining the
quantities of calcified plaques in the LAD is more sensitive
for the detection of severe angiographic disease, whereas
defining the quantities of calcified plaques in the LCx is
more specific.
The interpretation of coronary angiograms in the current
study was subject to the considerable intra- and interob-
server variability reported in previous studies (36). However,
the probability of systemic errors was low, because the
angiograms were prospectively interpreted based on the
agreement of two experienced, blinded angiographers.
Intra- and interobserver variability of EBCT calcium scores
has been reported to be negligible (37).
Conclusions. We have proposed a NI for the identification
of severe angiographic CAD in symptomatic patients. This
index, derived from a specific initial patient cohort, seems to
be useful for establishing a high (65–100%) as opposed to a
low (0–5%) probability of angiographic three-vessel and/or
left main disease in most patients. It may thus facilitate
individual decision-making concerning the urgency of cor-
onary catheterization in symptomatic patients. However,
this needs to be confirmed in a much larger prospective
study design.
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